(Q42174830)

English

Factors associated with the effect of interferon-α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B.

scientific article published on 15 January 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Factors associated with the effect of interferon-α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Kazuaki Chayama

7

object named as

Kazuaki Chayama

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

6

object named as

Masataka Tsuge

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Yoshiyuki Suzuki

4

object named as

Yoshiyuki Suzuki

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Yasuhito Tanaka

15

object named as

Yasuhito Tanaka

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

17

object named as

Eiji Tanaka

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Akihiro Matsumoto

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Hiroshi Yatsuhashi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Shinya Nagaoka

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Tatsuo Kanda

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Osamu Yokosuka

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Shuhei Nishiguchi

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Masaki Saito

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Shiho Miyase

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Jong-Hon Kang

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Noboru Shinkai

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Takeji Umemura

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

4 February 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Hepatology Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

45

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1195-1202

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Management of hepatitis B: summary of a clinical research workshop

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Hepatitis B reactivation after lamivudine

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

A partially overlapping treatment course with lamivudine and interferon in hepatitis B e antigen-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Antigenic and physicochemical characterization of the 2nd International Standard for hepatitis B virus surface antigen (HBsAg).

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12488

21 January 2018

Identifiers

10.1111/HEPR.12488

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25594111%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42174830&oldid=2136951673"